Repositorio Dspace
Response to therapy and prognosis according to molecular characterization in CALR-mutated essential thrombocythemia
JavaScript is disabled for your browser. Some features of this site may not work without it.
Mostrar el registro sencillo del ítem
| dc.contributor.author | Santaliestra, Marta | |
| dc.contributor.author | Garrote, Marta | |
| dc.contributor.author | Fernández-rodríguez, María-Concepción | |
| dc.contributor.author | Vélez, Patricia | |
| dc.contributor.author | Senin, Alicia | |
| dc.contributor.author | Arellano-Rodrigo, Eduardo | |
| dc.contributor.author | García-Gisbert, Neus | |
| dc.contributor.author | Longaron, Raquel | |
| dc.contributor.author | Pérez-Encinas, Manuel | |
| dc.contributor.author | Caballero-navarro, Gonzalo | |
| dc.contributor.author | Noya-Pereira, María-Soledad | |
| dc.contributor.author | Cuevas, Beatriz | |
| dc.contributor.author | Gómez-Casares, María-Teresa | |
| dc.contributor.author | Stuckey, Ruth | |
| dc.contributor.author | Carreno-tarragona, Gonzalo | |
| dc.contributor.author | Ferrer-Marín, Francisca | |
| dc.contributor.author | Cortés, Miguel-Ángel | |
| dc.contributor.author | Magro, Elena | |
| dc.contributor.author | Mata, Isabel | |
| dc.contributor.author | Angona, Anna | |
| dc.contributor.author | Pérez, Raul | |
| dc.contributor.author | Fox, María-Laura | |
| dc.contributor.author | Pastor-galan, Irene | |
| dc.contributor.author | Sastre, Paula | |
| dc.contributor.author | Triguero, Ana | |
| dc.contributor.author | García-Gutiérrez, Valentín | |
| dc.contributor.author | Hernández-Boluda, Juan-Carlos | |
| dc.contributor.author | Bellosillo, Beatriz | |
| dc.contributor.author | Álvarez-larran, Alberto | |
| dc.date.accessioned | 2026-04-06T11:09:50Z | |
| dc.date.available | 2026-04-06T11:09:50Z | |
| dc.date.issued | 2026-03 | |
| dc.identifier.citation | Santaliestra M, Garrote M, Fernández-Rodríguez MC, Vélez P, Senín A, Arellano-Rodrigo E, et al. Response to therapy and prognosis according to molecular characterization in CALR -mutated essential thrombocythemia. HemaSphere. marzo de 2026;10(3):e70325. doi:10.1002/hem3.70325 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/25669 | |
| dc.language.iso | eng | |
| dc.publisher | WILEY | |
| dc.rights | Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | * |
| dc.title | Response to therapy and prognosis according to molecular characterization in CALR-mutated essential thrombocythemia | |
| dc.type | info:eu-repo/semantics/article | |
| dc.relation.publisherversion | https://onlinelibrary.wiley.com/doi/10.1002/hem3.70325 | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dc.identifier.doi | 10.1002/hem3.70325 | |
| dc.journal.title | Hemasphere | |
| dc.identifier.essn | 2572-9241 |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional